Ocular Molecular Genetics Institute, Harvard Medical School, Massachusetts Eye and Ear Infirmary, 243 Charles Street, Boston, MA 02114, USA.
J Med Genet. 2010 Jul;47(7):499-506. doi: 10.1136/jmg.2009.075143. Epub 2010 May 27.
Usher syndrome type II (USH2) is an autosomal recessive disorder characterised by retinitis pigmentosa (RP) and mild to moderate sensorineural hearing loss. Mutations in the USH2A gene are the most common cause of USH2 and are also a cause of some forms of RP without hearing loss (ie, non-syndromic RP). The USH2A gene was initially identified as a transcript comprised of 21 exons but subsequently a longer isoform containing 72 exons was identified.
The 51 exons unique to the long isoform of USH2A were screened for mutations among a core set of 108 patients diagnosed with USH2 and 80 patients with non-syndromic RP who were all included in a previously reported screen of the short isoform of USH2A. For several exons, additional patients were screened.
In total, 35 deleterious mutations were identified including 17 nonsense mutations, 9 frameshift mutations, 5 splice-site mutations, and 4 small in-frame deletions or insertions. Twenty-seven mutations were novel. In addition, 65 rare missense changes were identified. A method of classifying the deleterious effect of the missense changes was developed using the summed results of four different mutation assessment algorithms, SIFT, pMUT, PolyPhen, and AGVGD. This system classified 8 of the 65 changes as 'likely deleterious' and 9 as 'possibly deleterious'.
At least one mutation was identified in 57-63% of USH2 cases and 19-23% of cases of non-syndromic recessive RP (calculated without and including probable/possible deleterious changes) thus supporting that USH2A is the most common known cause of RP in the USA.
Usher 综合征 II 型(USH2)是一种常染色体隐性疾病,其特征为视网膜色素变性(RP)和轻度至中度感觉神经性听力损失。USH2A 基因突变是 USH2 的最常见原因,也是一些无听力损失的 RP 形式(即非综合征性 RP)的原因。USH2A 基因最初被鉴定为由 21 个外显子组成的转录本,但随后鉴定出一种包含 72 个外显子的更长的异构体。
在先前报道的 USH2A 短异构体筛选中,对一组 108 例确诊为 USH2 的患者和 80 例非综合征性 RP 患者的核心组进行了筛选,以寻找仅存在于长异构体中的 51 个外显子的突变。对于几个外显子,还筛选了其他患者。
总共发现了 35 种有害突变,包括 17 种无义突变、9 种移码突变、5 种剪接位点突变和 4 种小的框内缺失或插入。27 种突变是新的。此外,还发现了 65 种罕见的错义变化。使用四个不同的突变评估算法(SIFT、pMUT、PolyPhen 和 AGVGD)的总和结果,开发了一种分类错义变化有害效应的方法。该系统将 65 个变化中的 8 个归类为“可能有害”,9 个归类为“可能有害”。
在 57-63%的 USH2 病例和 19-23%的非综合征性隐性 RP 病例(计算时不包括可能/可能有害的变化)中发现了至少一种突变,这支持 USH2A 是美国最常见的已知 RP 原因。